TENAX THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
TENAX THERAPEUTICS, INC. (TENX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2020-03-30
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2018 was $1.67M.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2017 was $0.00.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2014 was $292.36K, a 513.52% increase from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2018-12-31 | $1.67M 10-K · filed 2020-03-30 |
| 2017-12-31 | $0.00 10-K · filed 2019-04-01 |
| 2014-04-30 | $292.36K 10-K · filed 2014-07-29 |
| 2013-04-30 | $47.65K 10-K · filed 2014-07-29 |
| 2012-04-30 | $22.23K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |